Published 1993 | Version v1
Journal article

Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients

  • 1. Immunology Division, Cancer Research Institute, Parel, Bombay, 400012 (India)
  • 2. Tata Memorial Hospital, Tata Memorial Centre, Parel, Bombay, 400012 (India)

Description

Peripheral blood lymphocytes (PBL) and lymph node lymphocytes (LNL) from non-Hodgkin's lymphoma patients were tested for lymphokine-activated killer cells (LAK) cells cytotoxicity using appropriate targets in a short-term 51chromium-release assay. The results showed a significant depression in LNL-LAK activity suggesting the reduced capacity of LNL to generate LAK cells. LNL-LAK cells demonstrated significantly low percentages of cells expressing CD16, CD56 and CD25 as compared to PBL-LAK and healthy donors. The reduced capacity to generate LAK cells in lymph nodes could by due to the presence of low numbers of natural killer cells which are thought to be the main precursors of LAK cells. The IL-2 producing ability of lymph node mononuclear cells was found to by significantly higher than that of peripheral blood mononuclear cells from both healthy donors and and NHL patients. (author)

Additional details

Publishing Information

Journal Title
Neoplasma
Journal Volume
40
Journal Issue
1
Journal Page Range
p. 15-20
ISSN
0028-2685

Optional Information

Notes
3 tabs., 34 refs.